CAG repeat number governs the development rate of pathology in Huntington's disease.
about
Physiotherapy clinical guidelines for Huntington’s diseaseChaperone-like activity of high-mobility group box 1 protein and its role in reducing the formation of polyglutamine aggregatesObserving Huntington's Disease: the European Huntington's Disease Network's REGISTRYDetection of Motor Changes in Huntington's Disease Using Dynamic Causal Modeling.Multivariate clustering of progression profiles reveals different depression patterns in prodromal Huntington disease.Compensation in Preclinical Huntington's Disease: Evidence From the Track-On HD StudyHuntington’s disease blood and brain show a common gene expression pattern and share an immune signature with Alzheimer’s diseaseDisruption of response inhibition circuits in prodromal Huntington disease.Phonatory dysfunction as a preclinical symptom of Huntington disease.Biophysical insights into how surfaces, including lipid membranes, modulate protein aggregation related to neurodegeneration.Abnormal synchrony of resting state networks in premanifest and symptomatic Huntington disease: the IMAGE-HD study.Mutant huntingtin fragments form oligomers in a polyglutamine length-dependent manner in vitro and in vivo.Clinical and Biomarker Changes in Premanifest Huntington Disease Show Trial Feasibility: A Decade of the PREDICT-HD StudyPrediction of manifest Huntington's disease with clinical and imaging measures: a prospective observational studyFunctional magnetic resonance imaging of working memory in Huntington's disease: cross-sectional data from the IMAGE-HD study.Dynamics of the connectome in Huntington's disease: A longitudinal diffusion MRI study.Functional changes during working memory in Huntington's disease: 30-month longitudinal data from the IMAGE-HD study.Longitudinal Psychiatric Symptoms in Prodromal Huntington's Disease: A Decade of Data.Robust MR-based approaches to quantifying white matter structure and structure/function alterations in Huntington's disease.Effects of CAG repeat length, HTT protein length and protein context on cerebral metabolism measured using magnetic resonance spectroscopy in transgenic mouse models of Huntington's disease.Tractography of the corpus callosum in Huntington's disease.Biological and clinical manifestations of Huntington's disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data.High-resolution respirometry of fine-needle muscle biopsies in pre-manifest Huntington's disease expansion mutation carriers shows normal mitochondrial respiratory function.Impairment of developmental stem cell-mediated striatal neurogenesis and pluripotency genes in a knock-in model of Huntington's diseaseTopological length of white matter connections predicts their rate of atrophy in premanifest Huntington's disease.Neural correlates of impaired emotion processing in manifest Huntington's disease.Changes of peripheral TGF-β1 depend on monocytes-derived macrophages in Huntington diseaseGenome-wide RNA interference screen identifies previously undescribed regulators of polyglutamine aggregation.QEEG Measures in Huntington's Disease: A Pilot Study.Atomistic simulations of the effects of polyglutamine chain length and solvent quality on conformational equilibria and spontaneous homodimerizationA clinical classification acknowledging neuropsychiatric and cognitive impairment in Huntington's diseaseDifferential vulnerability of neurons in Huntington's disease: the role of cell type-specific features.No evidence of impaired gastric emptying in early Huntington's Disease.Fetal striatal grafting slows motor and cognitive decline of Huntington's disease.What is the impact of education on Huntington's disease?Nitric oxide and nitric oxide synthase in Huntington's disease.Age-at-onset in Huntington disease.The selective vulnerability of nerve cells in Huntington's disease.Deep white matter in Huntington's diseaseTracking motor impairments in the progression of Huntington's disease.
P2860
Q22305764-6CEC158E-2D78-4E69-92DF-899B11FDC5B8Q24307941-1808798E-54F4-4EC1-A962-62870A8251FAQ24598264-3AF17B0B-AFD6-423B-91B4-9B50087ADF52Q27317122-926FDE74-BF44-46AC-AE93-114C268AEB63Q27333729-090A8FE7-9E01-408B-AE57-BDE601E1F88FQ28393234-D83D6E1F-C19D-4F94-A3BD-4EE70FB547F7Q29248581-9236C122-8372-4894-9147-B67B55F65DA3Q30403689-774756E5-E85A-4652-A11A-2B0E4C8DB599Q30425545-A6036ACF-3C20-4C21-93DF-471549DB3D88Q30427825-3A3340DD-5BEA-4EE1-99E0-CAE0E82AE70CQ30441887-14CC1F33-CE50-4AE1-A630-8FDD33602259Q30494325-9E69A139-8CFC-483B-A75D-9FCF21F8E254Q30577157-EBE7FE64-8DE6-4D32-861C-23716910E440Q30631995-C2698EF3-2A32-4E52-8ED5-D51212A0C086Q30659199-C5AB81F2-620E-4929-BF18-82B39535C066Q30661031-E78DCB1B-27A5-4FBE-8294-75D7274C7A04Q30696281-6529A12A-4881-434D-86E8-66FFD5332E4BQ30855262-EE44F940-BDC6-423A-B84D-E2C60469B300Q30991345-3A07AB29-646E-4E1F-8BC4-37434D4B2C84Q31002507-F984E42E-7C06-4F8F-B9FA-46E20CB6E8D0Q31137452-1EBFAD88-EBDB-4DC1-9779-EEAC3DD0CAD9Q33489152-20956B86-6D2D-44F4-AE9B-22E5459CC444Q33562672-0D0E5350-B119-4B43-982C-8766AB11E4AAQ33564443-14DD1D56-0CBC-415B-B044-7AFC0F7BD0FEQ33579030-A7280424-49CF-48C8-A7FE-CE69170689E9Q33582389-E822300C-49CF-418C-AB2C-76B27DFD5D85Q33644718-6C890EB3-7062-4C2E-9C44-8427CD7B8CC8Q33694463-7424E0CF-A24B-43C4-8C76-217F4CCE09E8Q33734662-821E1E21-DE38-4FD6-A15B-83C84F5B6002Q33761386-52BD0457-AEB1-4474-B813-D740D1BD8C5AQ33929560-09953A8E-3A4E-49BF-AF8E-F30347E6327BQ33931283-A42BAE58-18B1-4AA7-A506-A87B4B9461E9Q34087126-3B6B72BA-15D6-4089-BC76-0C82D21CC8DBQ34092359-4DE92B66-16B5-4CFE-ACB3-17BE84921007Q34172955-0FD221E2-69C5-4178-BF98-9D7BBFE58BFFQ34208531-57CB7AC7-E311-450B-B23C-52B9DE70294EQ34210139-3A8E58AA-609C-4FE4-B40E-E5816776D0CCQ34216757-CA53FCB1-2629-4934-87AC-AC424BC86A8EQ34394979-A7CC9682-B786-4DD9-9C5F-A400CA8FCACEQ34449476-029A758C-F7DE-4160-9035-4C2282E6FEC6
P2860
CAG repeat number governs the development rate of pathology in Huntington's disease.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh-hant
name
CAG repeat number governs the development rate of pathology in Huntington's disease.
@en
CAG repeat number governs the development rate of pathology in Huntington's disease.
@nl
type
label
CAG repeat number governs the development rate of pathology in Huntington's disease.
@en
CAG repeat number governs the development rate of pathology in Huntington's disease.
@nl
prefLabel
CAG repeat number governs the development rate of pathology in Huntington's disease.
@en
CAG repeat number governs the development rate of pathology in Huntington's disease.
@nl
P2093
P2860
P356
P1433
P1476
CAG repeat number governs the development rate of pathology in Huntington's disease.
@en
P2093
MacDonald ME
Penney JB Jr
Vonsattel JP
P2860
P304
P356
10.1002/ANA.410410521
P577
1997-05-01T00:00:00Z